Acute Respiratory Infection (ARI) Treatment Support Protocol
Primary Stack
Core supplements with strongest evidenceInhibits viral replication in respiratory tract; started within 24 hours of symptoms can significantly reduce infection duration
Stimulates immune response and has direct antibacterial effects; reduces severity and duration of acute bronchitis and respiratory infections
Supporting Stack
Additional supplements for enhanced resultsSupports immune cell function; high doses during illness may reduce symptom severity and duration
Antiviral activity against influenza and some cold viruses; significantly reduces duration and severity of infection
Supports innate immunity; those with low levels benefit most from supplementation during infections
Reduces severity and duration of respiratory infection symptoms; has immunostimulatory effects
Supporting Studies (1)
Immunostimulant that may reduce cold duration when taken at first sign of symptoms
Soothes sore throat and reduces cough; may be more effective than some OTC cough medicines
Supporting Studies (1)
Mucolytic that thins mucus; may reduce duration and severity of respiratory infections
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Acute respiratory infections (ARIs) include the common cold, flu, bronchitis, and other viral infections affecting the respiratory tract. Most are caused by viruses and resolve on their own, but they cause significant discomfort and missed work or school. While there's no cure, certain supplements can help your immune system fight the infection faster and reduce symptom severity.
IMPORTANT: Most ARIs are viral and don't require antibiotics. However, seek medical attention if you have high fever, difficulty breathing, severe symptoms, symptoms lasting >10 days, or you're in a high-risk group. These supplements support recovery but don't replace medical care when needed.
Expected timeline: Start these supplements at the first sign of illness for best results. Zinc and elderberry can shorten illness by 1-3 days when started early. Most respiratory infections resolve within 7-10 days.
Clinical Perspective
Acute respiratory infections include upper (rhinitis, pharyngitis, sinusitis, otitis media) and lower (bronchitis, pneumonia) tract infections. Most are viral: rhinoviruses, coronaviruses, influenza, RSV, parainfluenza, adenoviruses. Typical duration 7-10 days; post-infectious cough may persist 2-4 weeks. Treatment is primarily supportive. Antibiotics are not indicated for uncomplicated viral ARIs. High-risk groups: elderly, immunocompromised, chronic cardiopulmonary disease.
CRITICAL: Red flags requiring medical evaluation: fever >39°C for >3 days, severe symptoms, dyspnea, symptoms >10-14 days without improvement, biphasic illness (improvement then worsening), immunocompromised status. Influenza with risk factors may warrant antivirals (within 48h).
Biomarker targets: Clinical endpoints (symptom severity/duration), self-limiting condition without specific biomarkers. CRP/procalcitonin if concerned about bacterial superinfection.
Protocol notes: Symptom management: acetaminophen/ibuprofen for fever/pain; saline nasal irrigation; humidified air; adequate hydration; rest. Honey for cough (ages >1 year). Avoid antitussives in productive cough (need to clear secretions). Decongestants for nasal congestion (short-term). Antihistamines have limited benefit for viral URI. Antibiotics are NOT indicated for uncomplicated viral infection—contributes to resistance. Hand hygiene prevents transmission. Influenza: antivirals (oseltamivir, zanamivir, baloxavir) if started within 48h in high-risk groups. Return to activities when afebrile 24h without antipyretics. Post-infectious cough may persist—usually resolves without treatment. Prevention: hand washing, avoid touching face, adequate sleep, vaccination.